{"podcast":{"title":"Business Of Biotech","slug":"business-of-biotech-123501","podcast_index_feed_id":123501,"rss_url":"https://rss.buzzsprout.com/1011661.rss","website_url":"https://www.bioprocessonline.com/solution/the-business-of-biotech-podcast","image_url":"https://storage.buzzsprout.com/35u0bccu9j9xpr9zrrjias54otax?.jpg","author":"Ben Comer","episode_count":310,"summary":"The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect.","last_synced_at":"2026-06-08T22:18:30.179389+00:00","page_url":"https://stenobird.com/podcast/business-of-biotech-123501"},"episode":{"title":"Bringing Curative Cell Therapies To Market with Kite Pharma's Cindy Perettie","slug":"bringing-curative-cell-therapies-to-market-with-kite-pharma-s-cindy-perettie","published_at":"2026-02-09T11:00:00+00:00","page_url":"https://stenobird.com/podcast/business-of-biotech-123501/bringing-curative-cell-therapies-to-market-with-kite-pharma-s-cindy-perettie","show_page_url":"https://stenobird.com/podcast/business-of-biotech-123501","url":"https://www.buzzsprout.com/1011661/episodes/18624039-bringing-curative-cell-therapies-to-market-with-kite-pharma-s-cindy-perettie.mp3","audio_url":"https://www.buzzsprout.com/1011661/episodes/18624039-bringing-curative-cell-therapies-to-market-with-kite-pharma-s-cindy-perettie.mp3","summary":"We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, we're speaking with Cindy Perettie, Executive Vice President and Global Head at Kite Pharma, a Gilead-owned company focused on curing cancer with cell therapies. Perettie talks about scaling cell therapies in the community setting, global manufacturing strategy, preparing for the launch of late-stage development programs in lymphoma and multiple myeloma, and working with partners like Ar...","meta_description":"We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, we're speaking with Cindy Perettie, Executive Vi…","key_points":[],"chapters":[],"topics":[],"duration_seconds":2556,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/business-of-biotech-123501/episodes/bringing-curative-cell-therapies-to-market-with-kite-pharma-s-cindy-perettie/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/business-of-biotech-123501/bringing-curative-cell-therapies-to-market-with-kite-pharma-s-cindy-perettie.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}